Head and Neck Cancer Research

Head and Neck Cancer Research

Research into head and neck cancer at Penn State Cancer Institute is conducted by the dedicated head and neck cancer team. See current clinical trials and members of that team here.

Clinical Trials

Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin
The COVID-19 and Cancer Consortium (CCC19) Registry
Head and Neck Cells: Tissue Repository
Understanding Factors that Impact Thyroid Cancer Incidence in Women
Research into head and neck cancer at Penn State Cancer Institute is conducted by the dedicated head and neck cancer team. See current clinical trials and members of that team here.
Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin
The COVID-19 and Cancer Consortium (CCC19) Registry
Head and Neck Cells: Tissue Repository
Understanding Factors that Impact Thyroid Cancer Incidence in Women

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)